8:00 – 8:15 AM
Age-related CD8 T Cells as Initators, Biomarkers, and Potential Therapeutic Targets in Sporadic Alzheimer’s
Senior Research Scientist SBMT; Chief Science Officer, T-Neuro Pharma; President, StemVax Therapeutics
8:15 – 8:30 AM
The Impact of Methionine Oxidation on Amyloid Beta 1-42 Aggregation
Ka Chan
Grad. Student UC Santa Cruz
8:30 – 8:45 AM
Testing the CAMPS Hypothesis: Improved Treatment for Neurodegenerative Diseases [CAMPS: Cytotoxic Aggregated Misfolded Polymorphic Structures]
William Rodman Shankle
University of California, Irvine
8:45 – 9:00 AM
A Step Closer to Early Alzheimer’s Diagnosis: The Power of an Ultrasensitive Blood Test
Ali Yanik
University of California, Santa Cruz
9:00 – 9:15 AM
CAA and ARIA in the Era of Anti-Amyloid Therapy
Edward Zamrini
TBD
9:15 – 9:30 AM
Q & A
Session Chairs
